Abnormal uterine bleeding, AUB
Conditions
Interventions
experimental group:Carbazochrome Tablets+Qi Jiao Tiaojing Granules
Sponsors
Changzhou Meternal and Child Health Care Hospital, Changzhou Medical Center, Nanjing Medical University
Eligibility
Sex/Gender
Female
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: 1. Meets the diagnosis of "menstrual prolongation" in Western medicine (normal menstrual cycle, menstrual duration exceeding 7 days, occurring for more than 2 consecutive cycles, intrauterine device without hormones is placed and in normal position); 2. According to traditional Chinese medicine diagnosis, it is classified as "deficiency of both qi and blood" (refer to "Guidelines for Clinical Research of New Chinese Medicines", presenting symptoms such as pale menstrual blood, fatigue, weakness, dizziness, etc.); 3. Age 18-45 years old, voluntarily participating in this study; 4. Within 3 months, no use of hormone-based drugs, and within 1 month, no use of hemostatic drugs.
Exclusion criteria
Exclusion criteria: 1. Organic lesions of reproductive organs (such as endometrial polyps, ovarian cancer, endometrial cancer, etc.); 2. Complicated with liver and kidney function, blood or immune system diseases, malignant tumors, etc.; 3. Pregnant or lactating women, those with allergic constitution or allergic to multiple drugs; 4. Within the last 2 months, using sex hormones or drugs affecting bleeding, or participating in other clinical trials within 1 month; 5. Abnormalities in coagulation function, endocrine, and thyroid function; 6. Clearly having menstrual disorders caused by other reasons or bleeding due to external genital and vaginal factors, ovulation disorders, local abnormalities of the endometrium.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Menstrual Function Improvement Rating Scale;Menstrual Rating Scale; | — |
Secondary
| Measure | Time frame |
|---|---|
| Interleukin-6;Interleukin-17A;Interleukin-17F;Tumor necrosis factor;Matrix metalloproteinase-9; | — |
Countries
China
Contacts
Public ContactWeiyang Chen
Changzhou Meternal and Child Health Care Hospital, Changzhou Medical Center, Nanjing Medical University
Outcome results
None listed